Clinical Trial Update: The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease [Phase 2]

View source ↗

Summary

This Phase 2 study in Non-alcoholic fatty liver disease investigates whether Helicobacter pylori eradication affects liver fat content; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Helicobacter pylori eradication therapy

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Fatty Liver, Liver Dysfunction | Phase 2 | Status: COMPLETED